Italy Research-grade Proteins Market Size & Outlook
Italy research-grade proteins market, 2018-2030 (US$M)
Related Markets
Italy research-grade proteins market highlights
- The Italy research-grade proteins market generated a revenue of USD 31.1 million in 2023 and is expected to reach USD 79.1 million by 2030.
- The Italy market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2023.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Research-grade proteins market data book summary
| Market revenue in 2023 | USD 31.1 million |
| Market revenue in 2030 | USD 79.1 million |
| Growth rate | 14.3% (CAGR from 2023 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
Other key industry trends
- In terms of revenue, Italy accounted for 3.2% of the global research-grade proteins market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK research-grade proteins market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 141.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research-grade Proteins Market Scope
Research-grade Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy research-grade proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 25.4% in 2023. Horizon Databook has segmented the Italy research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
According to the data by the International Trade Administration, the U.S. Department of Commerce, in October 2021, biopharmaceuticals, including monoclonal antibodies, advanced therapies, and recombinant proteins, accounted for around 45% of the projects in the pipeline in Italy, while recombinant proteins accounted for around 9% of all pharmaceutical product types sold.
The country also consists of 20 companies that developed 45 advanced therapy products, with the Lombardy region accounting for 43% of the research on therapeutics.
Furthermore, the country attracts various clinical trial activities due to the availability of advanced healthcare infrastructure and a large geriatric population. Key players are strengthening their production capacities to meet the growing demand for biopharmaceutical R&D and manufacturing.
Reasons to subscribe to Italy research-grade proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy research-grade proteins market databook
-
Our clientele includes a mix of research-grade proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Italy research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy research-grade proteins market size, by product, 2018-2030 (US$M)
Italy Research-grade Proteins Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
